MeOSuc-Ala-Phe-Lys-AMC TFA

製品番号: HY-P4347 純度: 98.30%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

MeOSuc-Ala-Phe-Lys-AMC TFA is a peptide substrate of plasmin.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

カスタムペプチド

MeOSuc-Ala-Phe-Lys-AMC TFA 構造式

CAS 番号 : 201853-92-1

容量	価格（税別）	在庫状況	数量
5 mg	$75	在庫あり	Estimated Time of Arrival: December 31
10 mg	$120	在庫あり	Estimated Time of Arrival: December 31
25 mg	$200	在庫あり	Estimated Time of Arrival: December 31
50 mg		お問い合わせ
100 mg		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

おすすめ

•関連小分子:

•関連タンパク質:

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

MeOSuc-Ala-Phe-Lys-AMC TFA is a peptide substrate of plasmin^[1].

分子量

749.73

分子式

C₃₅H₄₂F₃N₅O₁₀

CAS 番号

201853-92-1

Appearance

Solid

Color

White to off-white

Sequence

{MeOSuc}-Ala-Phe-Lys-{AMC}

Sequence Shortening

{MeOSuc}-AFK-{AMC}

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Sealed storage, away from moisture
Powder	-80°C	2 years
	-20°C	1 year
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 100 mg/mL (133.38 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.3338 mL	6.6691 mL	13.3381 mL
5 mM	0.2668 mL	1.3338 mL	2.6676 mL
10 mM	0.1334 mL	0.6669 mL	1.3338 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

純度とドキュメンテーション

純度: 98.30%

Select Batch:

データシート (270 KB) SDS (254 KB)

COA (249 KB) RP-HPLC (112 KB) MS (227 KB) Elemental Analysis Report (108 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Dall jl, et, al. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Cardiovasc Res. 2010 Jan 1;85(1):184-93. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.3338 mL	6.6691 mL	13.3381 mL	33.3453 mL
	5 mM	0.2668 mL	1.3338 mL	2.6676 mL	6.6691 mL
	10 mM	0.1334 mL	0.6669 mL	1.3338 mL	3.3345 mL
	15 mM	0.0889 mL	0.4446 mL	0.8892 mL	2.2230 mL
	20 mM	0.0667 mL	0.3335 mL	0.6669 mL	1.6673 mL
	25 mM	0.0534 mL	0.2668 mL	0.5335 mL	1.3338 mL
	30 mM	0.0445 mL	0.2223 mL	0.4446 mL	1.1115 mL
	40 mM	0.0333 mL	0.1667 mL	0.3335 mL	0.8336 mL
	50 mM	0.0267 mL	0.1334 mL	0.2668 mL	0.6669 mL
	60 mM	0.0222 mL	0.1112 mL	0.2223 mL	0.5558 mL
	80 mM	0.0167 mL	0.0834 mL	0.1667 mL	0.4168 mL
	100 mM	0.0133 mL	0.0667 mL	0.1334 mL	0.3335 mL